ARDS
Vanguard Group’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-136,197
| Closed | -$30K | – | 4628 |
|
|
2023
Q2 | $30K | Sell |
136,197
-388,959
| -74% | -$85.5K | ﹤0.01% | 4499 |
|
|
2023
Q1 | $165K | Buy |
525,156
+703
| +0.1% | +$221 | ﹤0.01% | 4343 |
|
|
2022
Q4 | $619K | Buy |
524,453
+331
| +0.1% | +$391 | ﹤0.01% | 4044 |
|
|
2022
Q3 | $488K | Hold |
524,122
| – | – | ﹤0.01% | 4216 |
|
|
2022
Q2 | $577K | Hold |
524,122
| – | – | ﹤0.01% | 4254 |
|
|
2022
Q1 | $922K | Buy |
524,122
+16,785
| +3% | +$29.5K | ﹤0.01% | 4233 |
|
|
2021
Q4 | $1.18M | Buy |
507,337
+337,800
| +199% | +$787K | ﹤0.01% | 4218 |
|
|
2021
Q3 | $624K | Buy |
169,537
+9,591
| +6% | +$35.3K | ﹤0.01% | 4344 |
|
|
2021
Q2 | $1.18M | Buy |
159,946
+10,288
| +7% | +$76.2K | ﹤0.01% | 4118 |
|
|
2021
Q1 | $883K | Buy |
149,658
+2,234
| +2% | +$13.2K | ﹤0.01% | 4041 |
|
|
2020
Q4 | $894K | Hold |
147,424
| – | – | ﹤0.01% | 3854 |
|
|
2020
Q3 | $1.04M | Buy |
147,424
+73,122
| +98% | +$518K | ﹤0.01% | 3650 |
|
|
2020
Q2 | $493K | Hold |
74,302
| – | – | ﹤0.01% | 3771 |
|
|
2020
Q1 | $429K | Hold |
74,302
| – | – | ﹤0.01% | 3704 |
|
|
2019
Q4 | $331K | Sell |
74,302
-7,664
| -9% | -$34.1K | ﹤0.01% | 3870 |
|
|
2019
Q3 | $551K | Buy |
81,966
+38,685
| +89% | +$260K | ﹤0.01% | 3795 |
|
|
2019
Q2 | $440K | Sell |
43,281
-2,384
| -5% | -$24.2K | ﹤0.01% | 3850 |
|
|
2019
Q1 | $502K | Buy |
+45,665
| New | +$502K | ﹤0.01% | 3769 |
|